STOCKHOLM, Sept. 13, 2018 /PRNewswire/ -- The shareholders
in IRRAS AB (publ), reg. no. 556872-7134 (the "Company"),
are hereby given notice to attend the extraordinary general meeting
held on Monday, 1 October 2018 at 10:00
a.m. (CEST) at the premises of Setterwalls Advokatbyrå with
address Sturegatan 10 in Stockholm,
Sweden. Registration for the meeting commences at
9:30 a.m. (CEST).
Notice
Shareholders wishing to participate at the meeting must:
(i) be entered in the shareholders' register, kept by Euroclear
Sweden AB (the Swedish Central Securities Depository & Clearing
Organisation), on the record day which is Tuesday 25 September 2018; and
(ii) notify the Company of their attendance and any assistant no
later than Tuesday 25 September 2018.
Notification can be made via letter to Setterwalls Advokatbyrå AB,
Attn: Linnea Björkstrand, P.O. Box 1050, SE-101 39 Stockholm, Sweden or by e-mail to
linnea.bjorkstrand@setterwalls.se.
Notification shall include full name, personal identification
number or corporate registration number, address and daytime
telephone number and, where appropriate, information about
representative, proxy and assistants. The number of assistants may
not be more than two. In order to facilitate entry to the meeting,
notification should, where appropriate, be accompanied by powers of
attorney, registration certificates and other documents of
authority.
Nominee registered shares
Shareholders who have their shares registered in the name of a
nominee must request temporary entry in the transcription of the
share register kept by Euroclear Sweden AB in order to be entitled
to participate and vote for their shares at the meeting. The
shareholder must inform the nominee well in advance of 25 September 2018, at which time the register
entry must have been made.
Proxy
A shareholder represented by proxy shall issue a power of
attorney which shall be dated and signed by the shareholder. If
issued by a legal entity the power of attorney shall be accompanied
by registration certificate or, if not applicable, equivalent
documents of authority. Power of attorney forms for those
shareholders wishing to participate by proxy are kept available as
is stated under "Documents" below. The power of attorney shall also
be presented in original at the
meeting.
Proposed agenda
- Opening of the meeting and election of chairman of the
meeting;
- Preparation and approval of the voting list;
- Approval of the agenda;
- Election of one or two persons who shall approve the minutes of
the meeting;
- Determination of whether the meeting has been duly
convened;
- Determination of the number of members of the board of
directors, election of new board member and determination of the
fees payable to the new board member; and
- Closing of the meeting.
The nomination committee's resolution proposals
The nomination committee is composed of the chairman of the
nomination committee Christer Hellström (appointed by Serendipity
Group AB and Serendipity Ixora AB) and the committee members
Anders P. Wiklund (chairman of the
board of directors in the Company), Christos Panotopoulos
(appointed by F.EX Endotherapy Limited) and Marios Fotiadis (appointed by Lexington Holding
Assets Limited (BVI) and Bacara Holdings Limited). The nomination
committee has presented the following resolution proposals in
relation to items 1 and 6 on the proposed
agenda.
Item 1. Election of chairman
The chairman of the board of directors, Anders P. Wiklund, is proposed as chairman of
the extraordinary general meeting.
Item 6. Determination of the number of members of the board
of directors, election of new board member and determination of the
fees payable to the new board member
The board of directors currently consists of the following five
(5) ordinary members: Anders P. Wiklund (chairman), Anita
Tollstadius, Kleanthis G.
Xanthopoulos (Ph.D.), Marios Fotiadis and Saeid Esmaeilzadeh (Ph.D.). The board of
directors has no deputy members. It is proposed that the board of
directors shall consist of six (6) ordinary members without deputy
members until the end of the next annual general meeting.
Eva Nilsagård is proposed to be elected as new board member for
the period until the end of the next annual general meeting, in
addition to the board members elected at the annual general meeting
of 2018.
It is proposed that the fees payable to Eva Nilsagård for the
period until the end of the next annual general meeting shall
amount to SEK 133,333 for ordinary
board work (corresponding to an annual fee of SEK 200,000) and SEK
66,666 for work as chairman of the Company's audit committee
(corresponding to an annual fee of 100,000).
Information regarding the proposed board member's principal
education and work experience, work performed for the Company and
any other significant professional commitments etc. as well as the
nomination committee's motivated statement pursuant to what is
stated in item 4.1 of the Swedish Corporate Governance Code, with
regards to the composition of the board of directors, is kept
available as is stated under "Documentation" below.
Shareholders' right to request information
Pursuant to Chapter 7 section 32 of the Swedish Companies Act
(Sw. aktiebolagslagen (2005:551)) the board of directors and the
managing director are under a duty to, if any shareholder so
requests and the board of directors deems that it can be made
without material damage to the Company, provide information,
regarding circumstances which may affect the assessment of a matter
on the agenda. Such duty to provide information also comprises the
Company's relation to the other group companies, the consolidated
financial statements and such circumstances regarding subsidiaries
which are set out in the foregoing sentence.
Number of shares and votes in the Company
The total number of shares and votes in the Company as of
12 September 2018 amounts to
24,017,974. The Company does not hold any of its own shares.
Documentation
Power of attorney forms and other documents to be addressed at
the extraordinary general meeting are kept available at the
Company's offices with address Vasagatan 16 in Stockholm, Sweden and will be sent free of
charge to shareholders who so request and state their postal
address. The documents are also kept available on the Company's
website www.irras.com. All the abovementioned documents will also
be presented at the extraordinary general meeting.
_____
Stockholm, September 2018
The board of directors
IRRAS AB (publ) is listed on Nasdaq First North Premier. Wildeco
is certified adviser of the Company.
For more information, please contact:
Fredrik Alpsten
CFO and Deputy CEO
+46-706-67-31-06
fredrik.alpsten@irras.com
About IRRAS
IRRAS AB (NASDAQ Stockholm: IRRAS) is a publicly-traded,
commercial-stage medical technology Company focused on developing
and commercializing innovative solutions for brain surgery. The
Company's initial product, IRRAflow®, addresses the
complications associated with the current methods of managing
intracranial fluid by using a dual lumen catheter that combines
active irrigation with ongoing fluid drainage.
Regularly during treatment, the IRRAflow catheter is
automatically flushed to prevent common catheter occlusions from
forming. Because IRRAflow is a completely closed system, it
is designed to reduce the documented infection risk of
these procedures. Additionally, IRRAflow incorporates ICP
monitoring and uses a proprietary software to regulate treatment
based on desired pressure levels.
With its unique product portfolio, protected by property patents
and patent applications, IRRAS is well positioned to establish a
leadership position in the medical device market. IRRAS maintains
its headquarters in Stockholm,
Sweden, with corporate offices in Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com.
This document is considered information that the Company is
obliged to disclose pursuant to the Nasdaq First North Rulebook.
The information was released for public disclosure, through the
agency of the contact person above, on September 13, 2018 at 07.00 a.m. (CET).
This information was brought to you by Cision
http://news.cision.com
http://news.cision.com/irras/r/notice-to-attend-the-extraordinary-general-meeting-in-irras-ab--publ-,c2617054
The following files are available for download:
http://mb.cision.com/Main/16550/2617054/908276.pdf
|
NOTICE TO ATTEND THE
EXTRAORDINARY GENERAL MEETING IN IRRAS AB (PUBL)
|